Zobrazeno 1 - 10
of 2 314
pro vyhledávání: '"Takashi Kojima"'
Autor:
Soh Yamamoto, Noriko Ogasawara, Yuka Sudo-Yokoyama, Sachiko Sato, Nozomu Takata, Nana Yokota, Tomomi Nakano, Kyoko Hayashi, Akira Takasawa, Mayumi Endo, Masako Hinatsu, Keitaro Yoshida, Toyotaka Sato, Satoshi Takahashi, Kenichi Takano, Takashi Kojima, Jun Hiraki, Shin-ich Yokota
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-15 (2024)
Abstract Human norovirus (HuNoV) is an enteric infectious pathogen belonging to the Caliciviridae family that causes occasional epidemics. Circulating alcohol-tolerant viral particles that are readily transmitted via food-borne routes significantly c
Externí odkaz:
https://doaj.org/article/f7e7aab5140f44c6b31706a36503eace
Publikováno v:
Drones, Vol 8, Iss 9, p 471 (2024)
In recent years, waste pollution has become a severe threat to riparian environments worldwide. Along with the advancement of deep learning (DL) algorithms (i.e., object detection models), related techniques have become useful for practical applicati
Externí odkaz:
https://doaj.org/article/d434c35ea5c541cd83c01d97f9d0f689
Autor:
Kazutaka Kamiya, Kimiya Shimizu, Akihito Igarashi, Yoshihiro Kitazawa, Takashi Kojima, Tomoaki Nakamura, Kazuo Ichikawa, Sachiko Fukuoka, Kahoko Fujimoto, the Japan ICL Study Group
Publikováno v:
Eye and Vision, Vol 11, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/540bbc22e1ff4138b259f26b2642a374
Autor:
Mashiro Okunaka, Daisuke Kotani, Hisashi Fujiwara, Kazuma Sato, Naoto Fujiwara, Saori Mishima, Shingo Sakashita, Takayuki Yoshino, Takeo Fujita, Takashi Kojima
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: Docetaxel, cisplatin, and 5-fluorouracil (DCF) combination chemotherapy has been established as one of the standard neoadjuvant therapies for locally advanced esophageal squamous cell carcinoma (ESCC). However, little is known about progn
Externí odkaz:
https://doaj.org/article/29bfe853d82041cea4eb26cffd0c06f2
Autor:
Naoya Sakamoto, Saori Mishima, Akihito Kawazoe, Yasutoshi Kuboki, Hideaki Bando, Takashi Kojima, Takayuki Yoshino, Takeshi Kuwata, Kohei Shitara, Yoshiaki Nakamura, Daisuke Kotani, Masashi Wakabayashi, Shohei Koyama, Hiroyoshi Nishikawa, Yosuke Tanaka, Shogo Takei, Itaru Endo, Motohiro Kojima, Toshihide Ueno, Hiroyuki Mano, Shota Fukuoka, Yi-Tzu Lin, Hiroki Hara, Shinya Kojima
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 2 (2024)
Background Immune checkpoint inhibitor (ICI) combinations represent an emerging treatment strategies in cancer. However, their efficacy in microsatellite stable (MSS) or mismatch repair-proficient (pMMR) colorectal cancer (CRC) is variable. Here, a m
Externí odkaz:
https://doaj.org/article/2be9529f9843474fb27cb25f1bcfd88c
Autor:
Shota Fukuoka, Yoshikatsu Koga, Mayumi Yamauchi, Shigehiro Koganemaru, Masahiro Yasunaga, Kohei Shitara, Toshihiko Doi, Takayuki Yoshino, Toshio Kuronita, Brian Elenbaas, Pamela Wahra, Hong Zhang, Lindsey Crowley, Molly H. Jenkins, Anderson Clark, Takashi Kojima
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-17 (2023)
Abstract The PI3K-Akt-mTOR (PAM) pathway is implicated in tumor progression in many tumor types, including metastatic gastric cancer (GC). The initial promise of PAM inhibitors has been unrealized in the clinic, presumably due, in part, to the up-reg
Externí odkaz:
https://doaj.org/article/f0c48d0b34094711b83db45840b8cc94
Autor:
Junyan Du, Shun-Ichiro Kageyama, Riu Yamashita, Kosuke Tanaka, Masayuki Okumura, Atsushi Motegi, Hidehiro Hojo, Masaki Nakamura, Hidenari Hirata, Hironori Sunakawa, Daisuke Kotani, Tomonori Yano, Takashi Kojima, Yamato Hamaya, Motohiro Kojima, Yuka Nakamura, Ayako Suzuki, Yutaka Suzuki, Katsuya Tsuchihara, Tetsuo Akimoto
Publikováno v:
Communications Biology, Vol 6, Iss 1, Pp 1-13 (2023)
Abstract Radiotherapy (RT) plus immunotherapy is a promising modality; however, the therapeutic effects are insufficient, and the molecular mechanism requires clarification to further develop combination therapies. Here, we found that the RNA virus s
Externí odkaz:
https://doaj.org/article/2c635e8b72ff436290dfe707e7042414
Autor:
Norikazu Matsuo, Koichi Azuma, Kenta Murotani, Daiki Murata, Goushi Matama, Akihiko Kawahara, Takashi Kojima, Takaaki Tokito, Tomoaki Hoshino
Publikováno v:
Thoracic Cancer, Vol 14, Iss 15, Pp 1362-1367 (2023)
Abstract Background The presence of cachexia in cancer patients negatively affects the quality of life and survival. However, the impact of cachexia on immunotherapy, such as PD‐1/L1 inhibitors, is not fully understood. Therefore, we examined wheth
Externí odkaz:
https://doaj.org/article/48a680446ad7427e97f1d0d70552a549
Autor:
Kazunari Higa, Reona Kimoto, Takashi Kojima, Murat Dogru, Wolfgang G. K. Müller-Lierheim, Jun Shimazaki
Publikováno v:
Pharmaceutics, Vol 16, Iss 4, p 523 (2024)
The temporal change in concentration of a novel medicine, Latanoprost (LP), was evaluated in the aqueous humor of rats (6–8-week-old Jcl:Wister rats) when delivered in a very-high-molecular-weight hyaluronic acid (vHiHA) eye drop. Animals were rand
Externí odkaz:
https://doaj.org/article/52bc38743171464b831e18bae76cff0d
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 5, p 2759 (2024)
Pendrin and prestin are evolutionary-conserved membrane proteins that are essential for normal hearing. Dysfunction of these proteins results in hearing loss in humans, and numerous deafness-associated pendrin and prestin variants have been identifie
Externí odkaz:
https://doaj.org/article/bcd9470450c24f98a08175325ceac523